| Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes H Dolatshad, A Pellagatti, FG Liberante, M Llorian, E Repapi, V Steeples, ... Leukemia 30 (12), 2322-2331, 2016 | 137 | 2016 |
| The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export J Vohhodina, EM Barros, AL Savage, FG Liberante, L Manti, P Bankhead, ... Nucleic acids research 45 (22), 12816-12833, 2017 | 93 | 2017 |
| Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression S Terlecki-Zaniewicz, T Humer, T Eder, J Schmoellerl, E Heyes, ... Nature structural & molecular biology 28 (2), 190-201, 2021 | 62 | 2021 |
| Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study J Busby, K Mills, SD Zhang, FG Liberante, CR Cardwell Breast Cancer Research 20, 1-10, 2018 | 49 | 2018 |
| HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy GJ Dickson, FG Liberante, LM Kettyle, KA O’Hagan, DPJ Finnegan, ... Haematologica 98 (8), 1216, 2013 | 46 | 2013 |
| Repurposing medicinal compounds for blood cancer treatment B McCabe, F Liberante, KI Mills Annals of hematology 94, 1267-1276, 2015 | 42 | 2015 |
| Cell survival responses after exposure to modulated radiation fields C Trainor, KT Butterworth, CK McGarry, F Liberante, JM O'Sullivan, ... Radiation research 177 (1), 44-51, 2012 | 39 | 2012 |
| Prediction of prime editing insertion efficiencies using sequence features and DNA repair determinants J Koeppel, J Weller, EM Peets, A Pallaseni, I Kuzmin, U Raudvere, ... Nature Biotechnology 41 (10), 1446-1456, 2023 | 30 | 2023 |
| Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8 AD Chacko, F Liberante, I Paul, DB Longley, DA Fennell BMC cancer 10, 1-8, 2010 | 30 | 2010 |
| Cancer-associated SF3B1 mutations confer a BRCA-like cellular phenotype and synthetic lethality to PARP inhibitors KM Lappin, EM Barros, SS Jhujh, GW Irwin, H McMillan, FG Liberante, ... Cancer research 82 (5), 819-830, 2022 | 24 | 2022 |
| High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation. FG Liberante, A Pellagatti, V Boncheva, DT Bowen, KI Mills, J Boultwood, ... British journal of haematology 162 (2), 2013 | 20 | 2013 |
| Chronic loss of STAG2 leads to altered chromatin structure contributing to de-regulated transcription in AML JS Smith, KM Lappin, SG Craig, FG Liberante, CM Crean, SS McDade, ... Journal of Translational Medicine 18, 1-18, 2020 | 19 | 2020 |
| A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties J Busby, L Murray, K Mills, SD Zhang, F Liberante, CR Cardwell Pharmacoepidemiology and Drug Safety 27 (1), 78-86, 2018 | 19 | 2018 |
| Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia FG Liberante, T Pouryahya, MF McMullin, SD Zhang, KI Mills Oncotarget 7 (6), 6609, 2016 | 19 | 2016 |
| Postdiagnostic Calcium channel blocker use and breast cancer mortality: A population-based cohort study J Busby, K Mills, SD Zhang, FG Liberante, CR Cardwell Epidemiology 29 (3), 407-413, 2018 | 14 | 2018 |
| Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability FG Liberante, K Lappin, EM Barros, J Vohhodina, F Grebien, KI Savage, ... Scientific Reports 9 (1), 2678, 2019 | 12 | 2019 |
| Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study BM Hicks, J Busby, K Mills, FA O’Neil, SA McIntosh, SD Zhang, ... BMC cancer 20, 1-12, 2020 | 11 | 2020 |
| The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells K Clarke, C Young, F Liberante, MF McMullin, A Thompson, K Mills Oncotarget 10 (37), 3462, 2019 | 9 | 2019 |
| An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mapping G Thillaiyampalam, F Liberante, L Murray, C Cardwell, K Mills, SD Zhang BMC bioinformatics 18, 1-16, 2017 | 8 | 2017 |
| Predicting efficiency of writing short sequences into the genome using prime editing J Koeppel, EM Peets, J Weller, A Pallaseni, F Liberante, L Parts bioRxiv, 2021.11. 10.468024, 2021 | 7 | 2021 |
Lars BullingerCharité University Medicine BerlinVerified email at charite.de
